Market revenue in 2023 | USD 59,852.9 million |
Market revenue in 2030 | USD 88,812.0 million |
Growth rate | 5.8% (CAGR from 2023 to 2030) |
Largest segment | Manufacturing |
Fastest growing segment | Research |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Manufacturing, Research |
Key market players worldwide | Catalent Inc, Pharmaceutical Product Development, AbbVie Inc, Baxter International Inc, Grifols SA Ordinary Shares - Class A, Dalton Pharma Services, Boehringer Ingelheim, Lonza Group Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical contract manufacturing and research services market will help companies and investors design strategic landscapes.
Manufacturing was the largest segment with a revenue share of 66.25% in 2023. Horizon Databook has segmented the U.S. pharmaceutical contract manufacturing and research services market based on manufacturing, research covering the revenue growth of each sub-segment from 2018 to 2030.
Presence of a large number of companies that are continuously expanding their manufacturing facilities to meet the growing need for biologics is likely to be responsible for the substantial growth of the pharmaceutical contract manufacturing and research services market in this country.
Moreover, presence of regulations, such as the FD&C Act, which monitors and refrains any individual from introducing adulterated or misbranded drugs, is expected to positively influence the growth of this market in the coming years.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. pharmaceutical contract manufacturing and research services market, including forecasts for subscribers. This country databook contains high-level insights into U.S. pharmaceutical contract manufacturing and research services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account